Clinical Trials Logo

Psoriasis clinical trials

View clinical trials related to Psoriasis.

Filter by:

NCT ID: NCT03886246 Active, not recruiting - Clinical trials for Generalized Pustular Psoriasis

Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

Start date: May 27, 2019
Phase: Phase 2
Study type: Interventional

This study is open to people with generalized pustular psoriasis (GPP). People can only take part if they have completed treatment in a previous study with spesolimab (1368-0013 or 1368-0027). The goal of this study is to find out how well people with GPP tolerate long-term treatment with spesolimab. The study also tests whether spesolimab helps improve GPP symptoms and how quickly the symptoms improve after a flare-up. Every participant gets spesolimab for almost 5 years (252 weeks). Depending on their symptoms and whether they had a GPP flare during the previous trial, they get spesolimab every few weeks. When participants have a GPP flare during this trial, they get spesolimab as an infusion into a vein. Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. To assess the study endpoints, doctors regularly check participants' skin.

NCT ID: NCT03885089 Completed - Psoriasis Vulgaris Clinical Trials

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Start date: October 21, 2019
Phase:
Study type: Observational

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against psoriasis vulgaris, psoriasis arthropathica, pustular psoriasis, or erythrodermic psoriasis under actual status of use.

NCT ID: NCT03880357 Completed - Scalp Psoriasis Clinical Trials

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

Start date: October 22, 2018
Phase: Phase 1
Study type: Interventional

To demonstrate the superiority of the efficacy of the test and reference products over that of the placebo control in the treatment of scalp psoriasis.

NCT ID: NCT03875508 Completed - Psoriasis Clinical Trials

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Start date: June 4, 2019
Phase: Phase 3
Study type: Interventional

The objectives of this study were to evaluate the usability of the combination product of risankizumab in an autoinjector (AI), as well as to evaluate the efficacy, safety, and tolerability of risankizumab administered by AI for the treatment of adult participants with moderate to severe plaque psoriasis.

NCT ID: NCT03875482 Completed - Psoriasis Clinical Trials

A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Start date: May 13, 2019
Phase: Phase 3
Study type: Interventional

The primary objective of this study was to evaluate the safety and efficacy of risankizumab (150 mg/mL) administered by prefilled syringe (PFS) for the treatment of adult participants with moderate to severe plaque psoriasis.

NCT ID: NCT03874975 Not yet recruiting - Psoriasis Vulgaris Clinical Trials

Combined Oral Vitamin D and UVB Versus UVB Alone in Treatment of Psoriasis Vulgaris

Start date: April 1, 2019
Phase: Early Phase 1
Study type: Interventional

To compare the results of vitamin D plus UVB in treatment of psoriasis vulgaris with the results of UVB alone to study the relation between serum vitamin D and PASI score before and after treatment.

NCT ID: NCT03873415 Completed - Psoriasis Clinical Trials

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Start date: January 25, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate sites of gut absorption of BMS-986165 in males

NCT ID: NCT03873142 Completed - Psoriasis Clinical Trials

The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With Eczema

Start date: October 19, 2018
Phase: N/A
Study type: Interventional

This study investigates the impact of a mindful parenting intervention on parents of children with psoriasis or eczema. More specifically, this study will investigate the impact of the group on both the child and the parents mental health and quality of life.

NCT ID: NCT03865030 Completed - Psoriasis Clinical Trials

The Inner Ear Function in Psoriatic Patients

MP
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Psoriasis in a systemic disease that effects many systems of the body. few studies examined the hearing function of these patients but the results were inconclusive. No study, however, investigated the vestibular function of psoriatic patients. In a prospective study, the investigators will compare audiovestibular function between psoriatic patients and healthy volunteers. .

NCT ID: NCT03864809 Not yet recruiting - Sleep Disturbance Clinical Trials

• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them

Start date: June 1, 2019
Phase:
Study type: Observational

Comparison between sleep disturbance in atopy and psoriasis and control